Literature DB >> 9278218

Host genetic factors influencing the outcome of hepatitis.

M R Thursz1.   

Abstract

A strong genetic component determining the outcome of hepatitis B virus (HBV) infection has been established through twin studies. The immunopathogenesis of HBV infection is well described and it has therefore been possible to predict some gene loci, exhibiting polymorphism, may influence the outcome of HBV infection. As expected, the immune response genes in the major histocompatibility complex (MHC) on the short arm of chromosome 6 have provided confirmed susceptibility genes. In hepatitis C virus (HCV) infection the picture is not so clear although comparison of the known immunological phenomena with those of HBV suggest that polymorphisms in the MHC may also influence disease outcome. Identification of susceptibility genes, which modify disease phenotype, may assist in predicting natural outcome of infection or response to therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9278218     DOI: 10.1046/j.1365-2893.1997.00052.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

1.  C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

Authors:  M Tevfik Dorak; Gbolahan O Folayan; Santosh Niwas; Dirk J van Leeuwen; Leland J Yee; Jianming Tang; Richard A Kaslow
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.

Authors:  Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 3.  Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection.

Authors:  Semra Tunçbilek
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population.

Authors:  Liang-Ping Lu; Xing-Wang Li; Ying Liu; Guo-Chang Sun; Xue-Ping Wang; Xi-Lin Zhu; Quan-You Hu; Hui Li
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

5.  Role of host genetic factors in the outcome of hepatitis C virus infection.

Authors:  Bertram Bengsch; Robert Thimme; Hubert E Blum
Journal:  Viruses       Date:  2009-08-05       Impact factor: 5.818

6.  Sero-prevalence and trends of transfusion-transmissible infections among blood donors at Bahir Dar district blood bank, northwest Ethiopia: A four year retrospective study.

Authors:  Elias Shiferaw; Wasihun Tadilo; Iyasu Melkie; Mikru Shiferaw
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

7.  Prevalence of Hepatitis B Virus and Hepatitis C Virus Among Blood Donors in Nekemte Blood Bank, Western Oromia, Ethiopia: Retrospective 5 Years Study.

Authors:  Milkias Abebe; Birhan Alemnew; Sirak Biset
Journal:  J Blood Med       Date:  2020-12-31

8.  Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis.

Authors:  Mulugeta Melku; Sintayehu Ambachew; Bamlaku Enawgaw; Molla Abebe; Zegeye Abebe; Tekalign Deressa; Debasu Damtie; Belete Biadgo; Belay Tessema; Demeke Geremew; Asemarie Kebede; Berhanu Woldu; Takele Teklu; Elias Shiferaw
Journal:  BMC Infect Dis       Date:  2021-08-09       Impact factor: 3.090

9.  Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus.

Authors:  Yuan-yong Xu; Ji-yun Yu; Yan-wei Zhong; Hong-bin Song; Hui-hui Liu; Lei-li Jia; Shen-long Li; Jian-qiu Xu; Qiao Li
Journal:  Int J Biol Sci       Date:  2008-04-25       Impact factor: 6.580

10.  Polarisation of major histocompatibility complex II host genotype with pathogenesis of European Brown Hare syndrome virus.

Authors:  Christos Iacovakis; Zissis Mamuris; Katerina A Moutou; Antonia Touloudi; Anne Sofie Hammer; George Valiakos; Themis Giannoulis; Costas Stamatis; Vassiliki Spyrou; Labrini V Athanasiou; Maria Kantere; Tommy Asferg; Alexios Giannakopoulos; Charlotte M Salomonsen; Dimitrios Bogdanos; Periklis Birtsas; Liljana Petrovska; Duncan Hannant; Charalambos Billinis
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.